APC and carcinoma: When activated by Cre recombinase, we found that the PID transgene effectively suppressed endogenous Group I Pak activity in vivo, and that such reduction resulted in a marked reduction in the number and progression of adenomas to carcinoma in an Apc-driven model of CRC.